SCHEMBL30734211

SCHEMBL30734211

CC(C)(C)OC(=O)n1cc(-c2ccc3ncnc(N4CCCN(Cc5ccc(F)cc5)CC4)c3c2)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.49
BACE1 P56817 4/20 0.49
AURKA O14965 1/20 0.49
HTT P42858 2/20 0.42
OPRM1 P35372 1/20 0.40
OPRK1 P41145 1/20 0.40
PDGFRB P09619 1/20 0.40
PDGFRA P16234 1/20 0.40
PIK3CG P48736 2/20 0.39
PI4KA P42356 1/20 0.39
PIK3CA P42336 4/20 0.39
KIT P10721 1/20 0.39
AKT1 P31749 1/20 0.39
RPS6KB1 P23443 1/20 0.39
LMNA P02545 1/20 0.39
PIK3CD O00329 1/20 0.39
PIK3CB P42338 1/20 0.39
MTOR P42345 1/20 0.39
ROCK2 O75116 1/20 0.39
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30734186 0.80 ACHE (0.60) ACHEBACE1AURKAHTTPIK3CA
SCHEMBL30734139 0.77 ACHE (0.56) ACHEBACE1AURKAHTTKIT
SCHEMBL30734191 0.75 ACHE (0.55) ACHEBACE1AURKAHTTOPRM1
SCHEMBL30734208 0.73 HTT (0.61) ACHEBACE1AURKAHTTOPRM1
SCHEMBL30734134 0.71 ACHE (0.58) ACHEBACE1AURKAHTTAKT1
SCHEMBL31029565 0.70 PIK3CG (0.61) PIK3CGPI4KAPIK3CAPIK3CDPIK3CB
SCHEMBL31029734 0.69 PIK3CG (0.60) PIK3CGPI4KAPIK3CAPIK3CDPIK3CB
SCHEMBL30333401 0.69 PIK3CG (0.60) PIK3CGPI4KAPIK3CAPIK3CDPIK3CB
SCHEMBL30734148 0.69 HTT (0.67) ACHEBACE1AURKAHTTKIT
SCHEMBL31029606 0.68 PIK3CG (0.56) PIK3CGPI4KAPIK3CAKITPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382301-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF UNIV ARIZONA (US) 2025-12-18 US disclosed
EP-4543888-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF Arizona Board of Regents on behalf of The University of Arizona (US) 2025-04-30 EP disclosed
WO-2023250083-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2023-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382301-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF CLK2, CLK3, CLK1 ACHE 3704/4885BACE1 1412/4885AURKA 397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.